We build and empower transformational healthcare
companies by pushing innovation boundaries
and forming operating platforms

Firm

Established in 2014 with the entrepreneurial vision and drive to build, grow and transform healthcare businesses across Asia, CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia, with offices in Singapore, Shanghai, New York, Beijing and Hong Kong

CBC is focused on platform-building and buyout opportunities across three core areas within the healthcare sector: pharmaceutical & biotech, medtech and healthcare services. CBC’s operationally intensive approach empowers healthcare sector champions to make transformative changes that enable sustainable long-term growth, fulfil unmet medical needs and continuously push the boundaries of healthcare innovation

Our current portfolio covers a number of sectors including biopharma, drug distribution, molecular diagnosis, medical devices and medical services. Through utilizing its capital resources and robust value-add services, CBC Group is committed to accelerating the R&D and commercialization of modern medical and pharmaceutical technologies, improving health and healthcare systems for the benefit of all people

Currently, CBC Group has a team of over 60 distinguished medical, investment and operational professionals focused on building the most trusted partner in China healthcare

We have partnered and are supported by world-class institutional investors spanning all major continents

 
30445a28a2a359aabce751e0396481a8.jpg
info@cbridgecap.com
www.cbridgecap.com
© 2020 CBC Group. All Rights Reserved.